Fortress Biotech repaid USD 15.00 million debt. Fortress Biotech stock is valued at USD 64.7 million
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
Fortress Biotech has repaid USD 15.00 million under its Oaktree credit facility on September 30, 2026, settling the remaining principal and accrued costs. This move strengthens the company's balance sheet, ending an agreement that began at USD 50.00 million. As of October 20, 2026, Fortress Biotech's stock was valued at USD 1.94, giving it a market capitalization of USD 64.7 million.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.